LumiraDX are a medical device company in the field of diagnostics, developing bespoke hardware and software for detecting medical conditions. Assays are created to identify a range of medical conditions, using microfluidic test strips.
Secured through competitive tendering, T-SQUARED was engaged as the preferred specialist partner to design, deliver, commission and validate a critical CL3 laboratory facility for LumiraDX.
Required to meet stringent physical and bio-security measures our project team, from the outset, worked in close liaison with both the client, clients landlord and other external agency consultants to ensure all critical functional criteria was implemented.
Designed to meet the exacting requirements of the Counter Terrorism Security Advisors (CTSA), Advisory Committee on Dangerous Pathogens (ACDP) and Loss Prevention Standard (LPS) 1175 security rating, this project demanded a careful approach to construction.
Architectural features included a fully enclosed secure envelope incorporating heavyweight blockwork walls and bonded security mesh to resist any external attack. Specialist internal surface coatings were applied to resist biological agents, regular cleaning and frequent fumigation as well as to ensure the required room negative pressurisation characteristics. Dedicated HVAC systems and other critical building services including specialist lab gases were integrated along with all electrical services including facility lighting, small power, datacoms and fire protection.
As part of this comprehensive turnkey delivery, T-SQUARED also procured, installed and tested the facility microbiological safety cabinets along with the dedicated autoclave provision.
Through unique professional collaborative working, our design and project management team exceeded all expectations ensuring the site has become a centre of research excellence.